In today’s news update we’ve provided links on the health care filibuster, oil and stem cell therapy.
Moderate and liberal Democrats unified behind a health care overhaul bill in the Senate today that critic Sen. John McCain dubbed “one of the great Bernie Maddoff gimmicks.”
Democrats broke a Republican filibuster in the wee hours of the morning and inched their sweeping $871 billion health care package toward passage before Christmas.
(Reuters) – Athersys Inc said it sold the rights of its stem-cell therapy to treat inflammatory bowel disease to Pfizer Inc, the world’s biggest drugmaker, and shares of Athersys nearly doubled in value.
Under the agreement, Pfizer will pay Athersys $6 million upfront and up to $105 million in milestones for the investigational stem cell therapy, MultiStem.
Athersys may elect to co-develop the therapy with Pfizer and both the companies will share expenses as well as profits and losses on an agreed basis, beginning at late-stage study, it said in a statement.